Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne L Peters

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
The American Journal of Managed Care|October 9, 2012
Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimensJennie H Best, John A Romley, Dana P Goldman, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 21, 2007
Food and park environments: neighborhood-level risks for childhood obesity in east Los AngelesMichele D Kipke, Ellen Iverson, Deborah Moore, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 25, 2021
Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 InhibitorRhea Teng, Martin Kurian, Kelly L Close, et al.
Diabetes Technology & Therapeutics|July 20, 2013
Continuous glucose monitoring pilot in low-income type 1 diabetes patientsPaola A Sequeira, Lucy Montoya, Valerie Ruelas, et al.
Current Medical Research and Opinion|March 10, 2004
Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetesAnne L Peters Harmel, David M Kendall, John B Buse, et al.
Diabetes Technology & Therapeutics|April 5, 2023
Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTERichard M Bergenstal, Elise Hachmann-Nielsen, Kajsa Kvist, et al.
Diabetes Care|March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia|March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetes Care|October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupJohn R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetologia|December 6, 2019
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working GroupG Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
The American Journal of Managed Care|October 9, 2012
Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimensJennie H Best, John A Romley, Dana P Goldman, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 21, 2007
Food and park environments: neighborhood-level risks for childhood obesity in east Los AngelesMichele D Kipke, Ellen Iverson, Deborah Moore, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|February 25, 2021
Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 InhibitorRhea Teng, Martin Kurian, Kelly L Close, et al.
Diabetes Technology & Therapeutics|July 20, 2013
Continuous glucose monitoring pilot in low-income type 1 diabetes patientsPaola A Sequeira, Lucy Montoya, Valerie Ruelas, et al.
Current Medical Research and Opinion|March 10, 2004
Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetesAnne L Peters Harmel, David M Kendall, John B Buse, et al.
Diabetes Technology & Therapeutics|April 5, 2023
Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTERichard M Bergenstal, Elise Hachmann-Nielsen, Kajsa Kvist, et al.
Diabetes Care|March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia|March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetes Care|October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupJohn R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetologia|December 6, 2019
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working GroupG Alexander Fleming, John R Petrie, Richard M Bergenstal, et al.
Pageof 13